These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8845074)

  • 21. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
    Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients.
    Raij L; Egan BM; Zappe DH; Purkayastha D; Samuel R; Sowers JR
    J Clin Hypertens (Greenwich); 2011 Oct; 13(10):731-8. PubMed ID: 21974760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
    Weir MR; Shojaee A; Maa JF
    Postgrad Med; 2013 Mar; 125(2):124-34. PubMed ID: 23816778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
    Manolis AJ; Grossman E; Jelakovic B; Jacovides A; Bernhardi DC; Cabrera WJ; Watanabe LA; Barragan J; Matadamas N; Mendiola A; Woo KS; Zhu JR; Mejia AD; Bunt T; Dumortier T; Smith RD
    Clin Ther; 2000 Oct; 22(10):1186-203. PubMed ID: 11110230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY; Ahn T; Bae JH; Lim DS; Lee SU; Kim YK; Hyon MS; Kim WH; Han KR; Park HK
    Clin Ther; 2014 Oct; 36(10):1402-11. PubMed ID: 25146365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.
    Chapman AB; Cotsonis G; Parekh V; Schwartz GL; Gong Y; Bailey KR; Turner ST; Gums JG; Beitelshees AL; Cooper-DeHoff R; Boerwinkle E; Johnson JA
    Am J Hypertens; 2014 Apr; 27(4):546-54. PubMed ID: 23886594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
    Pool JL; Glazer R; Crikelair N; Levy D
    Clin Drug Investig; 2009; 29(12):791-802. PubMed ID: 19888785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R; Taddei S; Holm-Bentzen M; Baszak J; Melani L; Schumacher K
    Clin Drug Investig; 2010; 30(9):581-97. PubMed ID: 20593911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2).
    Parati G; Bilo G; Redon J;
    Hypertens Res; 2013 Apr; 36(4):322-7. PubMed ID: 23154590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
    Ruilope LM; Heintz D; Brandão AA; Stolt P; Kandra A; Santonastaso M; Khder Y
    Blood Press Monit; 2005 Apr; 10(2):85-91. PubMed ID: 15812256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension.
    Coca A; Calvo C; Sobrino J; Gómez E; López-Paz JE; Sierra C; Bragulat E; de la Sierra A
    Clin Ther; 2003 Nov; 25(11):2849-64. PubMed ID: 14693309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
    Germino FW; Neutel JM; Dubiel R; Maa JF; Chavanu KJ
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):325-33. PubMed ID: 22920048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monotherapy with amlodipine or hydrochlorothiazide in patients with mild to moderate hypertension: Comparison of their efficacy and effects on electrolytes.
    Nwachukwu DC; Eze AA; Nwachukwu NZ; Aneke EI; Agu PU; Azubike NC; Obika LF; Okoye OI
    Malawi Med J; 2017 Jun; 29(2):108-112. PubMed ID: 28955416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S; Aurup P; Snavely D; Goldberg A
    Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.
    Johnson JA; Gong Y; Bailey KR; Cooper-DeHoff RM; Chapman AB; Turner ST; Schwartz GL; Campbell K; Schmidt S; Beitelshees AL; Boerwinkle E; Gums JG
    Clin Pharmacol Ther; 2009 Nov; 86(5):533-9. PubMed ID: 19571804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
    Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
    Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.